Balance Sheet for INmune Bio Inc. (INMB)

$ 8.57   -0.01 (-0.12%) Volume: 66.94k 3:34 PM EST 24-Nov-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016
Cash and Equivalents 6,996 186 1,371 142
Restrictable Cash - - - -
Marketable Securities - - - -
Accounts Receivable 645 648 328 260
Loans Receivable - - - -
Other Receivables - - - 156
Receivables 645 648 328 260
Inventories, Raw Materials - - - -
Inventories, Work in Progress - - - -
Inventories, Purchased Components - - - -
Inventories, Finished Goods - - - -
Inventories, Other - - - -
Inventories, Adjustments & Allowances - - - -
Inventories - - - -
Prepaid Expenses 124 16 201 49
Current Deferred Income Taxes - - - -
Other Current Assets - - - -
Total Current Assets 7,765 849 1,899 452
Land and Improvements - - - -
Buildings and Improvement 383 - - -
Machinery, Furniture and Equipment - - - -
Construction in Progress - - - -
Fixed Assets, Other (192) - - -
Fixed Assets, Total 192 - - -
Gross Fixed Assets 192 - - -
Accumulated Depreciation - - - -
Net Fixed Assets 192 - - -
Intangibles 16,514 16,514 16,514 -
Cost in Excess - - - -
Non-Current Deferred Income Taxes - - - -
Other Non-Current Assets - - - -
Total Non-Current Assets 16,706 16,514 16,514 -
Total Assets 24,470 17,363 18,413 452
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016
Accounts Payable 692 824 310 251
Short Term Debt 8 - - 350
Notes Payable - - - -
Accrued Expenses - - - -
Accrued Liabilities - - - -
Deferred Revenues 300 - - -
Current Deferred Income Taxes - - - -
Other Current Liabilities (300) - - -
Total Current Liabilities 700 824 310 601
Long Term Debt N/A N/A N/A -
Deferred Income Tax - - - -
Other Non-Current Liabilities - - - -
Minority Interest - - - -
Capital Lease Obligations 160 - - -
Preferred Securities of Subsidiary Trust - - - -
Preferred Equity Outside Shareholders' Equity - - - -
Total Non-Current Liabilities 160 - - -
Total Liabilities 861 824 310 601
Preferred Shareholder's Equity - - - -
Common Shareholder's Equity 23,610 16,540 18,104 (149)
Common Par 11 9 8 5
Additional Paid in Capital 44,834 25,446 19,171 125
Cumulative Translation Adjustments - - - -
Retained Earnings (21,276) (13,598) (1,158) (326)
Treasury Stock - - - -
Other Equity Adjustments (9) 7 32 (3)
Total Capitalization 23,610 16,540 18,104 (149)
Total Equity 23,610 16,540 18,104 (149)
Total Liabilities & Shareholder's Equity 24,470 17,363 18,413 452
Cash Flow (7,678) (12,440) (831) (277)
Working Capital 7,064 26 1,590 (149)
Free Cash Flow (5,385) (2,059) (862) (317)
Invested Capital 23,610 16,540 18,104 (149)
Shares Outstanding - Common Class Only 10,771 - - -
Preferred Shares Outstanding - - - -
Total Ordinary Shares 10,771 11,219 11,219 11,219
Total Common Shares Outstanding 10,771 - - -
Treasury Shares - - - -
Basic Weighted Shares Outstanding 10,273 11,219 11,219 11,219
Diluted Weighted Shares Outstanding 10,273 11,219 11,219 11,219